More Bad News for Niacin

More Bad News for Niacin: Health After 50.

 


Health After 50

 

More Bad News for Niacin

 

Comments (0)

 

Are you currently taking niacin to improve your cholesterol levels? If so, a conversation with your doctor may be warranted to determine whether you should continue taking niacin.

 

The reason for reconsidering niacin is twofold: First, a new study claims that the drug doesn’t help lower heart attack or stroke risk and may instead cause serious side effects. Second, studies haven’t been able to show that raising “good” HDL (high-density lipoprotein) cholesterol — one of the effects of niacin — has a benefit for people who already have heart disease.

 

For years, doctors have speculated on whether taking niacin to raise levels of HDL cholesterol could lower the risk of a heart attack, stroke or other cardiac events. The latest results from the recent HPS2-THRIVE trial, published by the New England Journal of Medicine, have answered with a resounding “no.”

 

This isn’t the first time niacin has been given the thumbs-down — past trials have reached similar conclusions, most notably the AIM-HIGH study of more than 3,400 patients on statin therapy. Researchers stopped that trial early in 2011 because of the apparent lack of benefit from niacin, along with reports of adverse events.

 

Dr. James L. Weiss, professor of cardiology at Johns Hopkins weighs in: “Higher HDL levels are associated with better heart outcomes, but that doesn’t mean they directly cause these better outcomes — an important distinction.

 

“Another way to look at it: Low HDL levels may be linked to an increased heart disease risk, but raising them with niacin doesn’t seem to reduce that risk. Still, it makes sense that you’d want more HDL cholesterol in your body.

 

“You can naturally increase levels by eating healthier foods, exercising regularly and quitting smoking. In the end, good health outcomes stem from making good lifestyle choices. For patients who stand to benefit from drug therapy, current guidelines recommend statins alone as the most effective therapy for reducing cardiovascular risk and suggest niacin for only selected high-risk patients for whom benefits outweigh risks.”

 

Posted in Heart Health on March 6, 2015

 


 

Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Health After 50 Disclaimer

Snorting bupropion – The Poison Review

Snorting bupropion | The Poison Review.

The abuse of bupropion by pulverizing and snorting the medication has been described at least as far back as 2002. Bupropion inhibits re-uptake of dopamine and norepinephrine, but apparently has little or no effect on serotonin. It is abused for its psychotropic effects that resemble those of amphetamine and cocaine..

A hallmark of overdose with sustained-release or extended-release bupropion formulations is delayed onset of seizures — sometimes more than 8 hours after ingestion. When these preparations are crushed and insufflated, absorption is rapid and manifestations would be expected to come on more quickly.

– See more at: http://www.thepoisonreview.com/2014/11/12/snorting-bupropion/#sthash.35NLtujG.dpuf

Neurotoxicity with Antimicrobials in the Elderly: A Review – Clinical Therapeutics

Yikes!

Neurotoxicity with Antimicrobials in the Elderly: A Review – Clinical Therapeutics.

Findings

Various antimicrobial classes are implicated with neurotoxicity. The classes with the most reported cases include fluoroquinolones, macrolides, sulfonamides, nitrofurans, and β-lactams. A higher risk of developing various symptoms of neurotoxicity was found in the elderly with use of piperacillin and tazobactam, cephalosporins, carbapenems, aminoglycosides, trimethoprim and sulfamethoxazole, nitrofurantoin, linezolid, and possibly the fluoroquinolones. Potential mechanisms of neurotoxicity differ between the agents. The etiology of neurotoxicity with some agents is not fully elucidated. Incidence may increase with reported risk factors, renal dysfunction, or drug interactions.